Skip to Main Content

Paper Details

An acetyl-histone vulnerability in PI3K/AKT inhibition-resistant cancers is targetable by both BET and HDAC inhibitors.
Cell Rep
16
2021
Author NameAffiliation
Yu-Tian XiaoShanghai Changhai Hospital
Shancheng RenWuxi Institute of Health Sciences of Beijing Institute of Genomics, Shanghai Changhai Hospital
  • 1 - 2

Datasets

Release 1.2